Nigerian Guava Leaves: The Agricultural By-Product That the Fruit Industry Discards as Waste and That the Global Botanical Supplement Market Pays Premium Prices to Source — Whose Clinical Evidence for Antidiarrheal, Blood Glucose Management, and Antimicrobial Applications Rivals That of Botanical Ingredients Whose International Trade Has Been Formally Established for Decades

 

Guava Leaves Exporter Nigeria — Dried Guava Leaves, Herbal Tea-Grade Guava Leaves, Extract-Grade Guava Leaves, Guava Leaf Powder, and Guava Leaf Extract Precursor, Direct Southern and Middle Belt Sourcing, Bulk Supply to Nutraceutical Supplement Brands, Herbal Tea Manufacturers, Pharmaceutical Raw Material Buyers, Traditional Medicine Producers, Functional Food Companies, and Global Specialty Wholesale Buyers Worldwide

 

Guava leaves exporter Nigeria is a search phrase that arrives carrying one of the most commercially instructive supply chain paradoxes in the entire botanical ingredient market: the global guava fruit industry — whose tropical production across Nigeria, India, Brazil, Thailand, Mexico, and Pakistan generates approximately 55 million metric tonnes of fresh guava annually according to FAO production statistics — creates a simultaneous by-product of billions of tonnes of guava leaves per year whose routine pruning, harvesting, and orchard management generates leaf material that the fruit industry categorises as agricultural waste, composts on-site, or burns as field residue.

The pharmaceutical and nutraceutical industry’s characterisation of the same material is entirely different. Guava leaf extract — containing quercetin, luteolin, apigenin, ellagic acid, guaijaverin, and the tannin-polyphenol complex whose combined biological activity profile has generated more than 1,500 peer-reviewed publications accessible via NCBI’s PubMed database — is sold in premium supplement retail at USD 25–60 per bottle of standardised guava leaf extract capsules. The same compound profile is sourced by herbal tea manufacturers whose guava leaf tea products sell across Japanese, Korean, and European natural food retail at premium positioning. The same raw material is purchased by pharmaceutical raw material suppliers whose standardised guava leaf extracts are incorporated in traditional medicine formulations whose evidence base includes human clinical trials.

The specific clinical applications whose evidence base creates this commercial demand are commercially instructive in their diversity and specificity:

Antidiarrheal activity — the most extensively clinically validated application, whose evidence includes randomised controlled trials in children with acute diarrhoea published through NCBI’s gastroenterology research database documenting significantly shorter illness duration and reduced stool frequency versus placebo. Guava’s antidiarrheal mechanism — quercetin and ellagic acid’s inhibition of intestinal smooth muscle hypermotility combined with tannin’s astringent mucus membrane effect — creates a multi-mechanism pharmacological basis for traditional antidiarrheal use that is documented across Nigeria, Brazil, India, and Southeast Asian traditional medicine systems simultaneously.

Blood glucose management — human clinical studies on guava leaf tea consumption in pre-diabetic and type 2 diabetic subjects — reviewed through NCBI’s endocrinology and metabolism research database — documenting significant post-meal blood glucose peak reduction (20–30% reduction in post-prandial glucose AUC) through alpha-glucosidase inhibitory activity of guava leaf polyphenols. This is a documented, human-trial-validated blood glucose management mechanism operating through a different pathway from cinnamon’s insulin sensitisation or berberine’s AMPK activation — creating complementary formulation interest for metabolic health supplement manufacturers building multi-mechanism blood glucose products.

Antimicrobial applications — guava leaf extract’s documented broad-spectrum antimicrobial activity against Staphylococcus aureus, E. coli, Salmonella typhi, Candida albicans, and antibiotic-resistant organisms — reviewed through Journal of Ethnopharmacology — creating pharmaceutical development interest in guava leaf as a natural antimicrobial agent whose broad-spectrum activity at relatively low minimum inhibitory concentrations creates antibiotic resistance research relevance documented through WHO’s antimicrobial resistance research programme.

Nigeria’s Psidium guajava cultivation — distributed across Ogun, Oyo, Ondo, Osun, Ekiti, Anambra, Imo, Enugu, Cross River, Kogi, Niger, and Plateau states where guava grows prolifically in both cultivated orchard and semi-wild farm boundary settings — creates a production base whose leaf harvesting represents a commercially valuable by-product extraction from an existing agricultural system rather than a new crop requiring dedicated cultivation investment.

At Paradise MultiTrade International Limited, guava leaves is a priority botanical product category — harvested from documented Nigerian Psidium guajava cultivation, processed into dried leaf, tea-grade cut-and-sifted, powder, and extract-grade material, and exported with full food safety, botanical authentication, and analytical documentation.

To discuss sourcing immediately, request a quotation here and our export team responds within 48 hours.

---

History and Origin — The American Native Whose Global Adoption Created a Botanical Medicine Legacy

Psidium Guajava — From Mesoamerican Origin to Pantropical Integration

Psidium guajava L. is native to Mexico, Central America, and the northern regions of South America — where pre-Columbian indigenous peoples cultivated and consumed both fruit and leaves in food and medicinal applications dating back approximately 5,000 years. Portuguese and Spanish maritime exploration of the 15th and 16th centuries distributed guava throughout the tropical world — to Africa, Asia, India, Southeast Asia, and the Pacific — with a speed and geographic completeness that reflects both the tree’s remarkable adaptability to diverse tropical conditions and the commercial value of its fruit and medicinal applications that every adopting culture discovered independently.

Guava’s arrival in West Africa — through Portuguese maritime traders — created rapid adoption in Nigerian, Ghanaian, and Cameroonian traditional medicine systems whose empirical observation of guava leaf’s antidiarrheal efficacy matched the traditional applications already documented in Brazil, India, and Southeast Asia. This multi-continental traditional use convergence — independent parallel discovery of the same antidiarrheal application across cultures that had no knowledge of each other’s botanical practices — is the same convergent empirical validation pattern documented for pumpkin seed’s prostate health prescription and ehuru’s aromatic convergence with Asian nutmeg — and carries the same weight as evidence of genuine biological activity.

The World Health Organization’s global traditional medicine strategy specifically identifies guava leaf as a botanical with documented traditional use across multiple WHO regions — whose integration into formal primary healthcare delivery in resource-limited settings is supported by the clinical evidence base whose strength, for the antidiarrheal application specifically, is among the most robust in botanical medicine.

Nigeria’s traditional medicine documentation — accessible through Journal of Ethnopharmacology‘s West African ethnobotany research programme — confirms guava leaf’s role in Yoruba (ogùrọ̀bì leaves), Igbo, and Hausa traditional healing for diarrhoea, dysentery, wound healing, and fever management — creating a specifically Nigerian traditional use heritage whose documentation supports the traditional use evidence basis that EU and US botanical supplement regulatory frameworks reference.

---

What Is Nigerian Guava Leaf? The Botanical Profile, Phytochemical Architecture, and Commercial Product Range

Psidium Guajava — The Polyphenol-Rich Leaf Whose Compound Profile Creates Multi-Application Commercial Value

Psidium guajava is a small to medium-sized evergreen tree of the Myrtaceae (myrtle) family — whose broad, ovate leaves (8–15cm long, 4–8cm wide) with characteristic opposite arrangement, prominent midrib, and slightly rough texture create the botanical morphology that distinguishes P. guajava from the multiple other Psidium species in cultivation. The commercial product is the leaf — harvested from young, mature branches before the leaf has aged to the point of reduced compound content — whose specific harvesting window between full leaf expansion and premature senescence maximises the polyphenol content that creates commercial value.

The Primary Bioactive Compounds:

Quercetin — approximately 70–100mg per gram of dried leaf — the same cardiovascular-protective, anti-inflammatory, antiviral flavonol documented in onion powder (whose quercetin content at 120–250mg per 100g dry weight is dramatically lower than guava leaf’s 7,000–10,000mg per 100g equivalent). Guava leaf’s quercetin concentration is among the highest documented in any commercially traded botanical — creating exceptional quercetin delivery per gram of leaf material.

Luteolin — approximately 30–50mg per gram of dried leaf — the flavone whose anti-inflammatory COX-2 inhibitory activity and documented antitumour activity in cell culture research creates nutraceutical positioning alongside quercetin.

Apigenin — the flavone specifically documented for its alpha-glucosidase inhibitory activity — the enzyme whose intestinal inhibition reduces the rate of dietary starch breakdown to glucose, creating the post-prandial blood glucose peak reduction documented in clinical studies on guava leaf tea.

Ellagic acid — the polyphenol whose documented antidiarrheal mechanism includes intestinal smooth muscle relaxation alongside the antimicrobial activity against the enteropathogens whose overgrowth drives infectious diarrhoea.

Guaijaverin — a quercetin glycoside specifically identified in P. guajava leaves — documented through Journal of Natural Products as a specific Psidium marker compound whose presence confirms species authenticity and whose antibacterial activity against Streptococcus mutans creates specific oral health antimicrobial positioning.

Condensed tannins (proanthocyanidins) — approximately 10–15% of dried leaf weight — the astringent polyphenolic fraction whose mucous membrane-binding activity creates the direct antidiarrheal effect (reducing intestinal secretion by protein-precipitating intestinal mucous membrane surface proteins) that operates alongside the smoother muscle inhibitory mechanism of flavonoids.

Essential oil — approximately 0.5–1.5% of fresh leaf weight — containing β-caryophyllene, α-humulene, and related sesquiterpenes whose antimicrobial and anti-inflammatory activity complements the polyphenol fraction.

Total phenolic content — approximately 150–300mg gallic acid equivalents per gram of dried leaf — placing guava leaf among the most phenolic-dense commonly traded botanical leaves — dramatically above green tea (approximately 15–25mg GAE/g), moringa leaf (approximately 8–15mg GAE/g), and most other commercially traded herbal teas.

Commercial Grade Definitions

Whole Dried Leaves (Tea Grade A) — large, intact leaves dried to below 10% moisture — the premium presentation for single herb herbal tea retail and specialty food service.

Cut and Sifted (Tea Grade B) — dried leaves mechanically cut to 3–8mm pieces — the standard form for tea bag filling, herbal infusion blending, and food service loose-leaf tea packaging.

Guava Leaf Powder — finely milled dried leaves to 80 mesh — for supplement capsule filling, functional food ingredient incorporation, and extract preparation.

Extract-Grade Dried Leaves — highest-quercetin-content lots specifically selected by analytical screening for extract manufacturing — the raw material for standardised guava leaf extract production.

---

Benefits and Industrial Uses of Nigerian Guava Leaves

Nutraceutical Supplement Industry — Quercetin, Blood Glucose, and Antidiarrheal

The global botanical supplement market’s multiple applications for guava leaf extract create distinct procurement communities whose combined demand creates commercially significant procurement volumes:

Blood glucose management supplement — the most commercially active application in the Japanese, Korean, and increasingly European supplement markets whose specific positioning as a post-meal blood glucose regulator creates a functional use mechanism distinct from competing blood glucose management ingredients. Research from Japan — specifically the studies published through NCBI documenting significant post-meal blood glucose peak reduction in pre-diabetic subjects consuming guava leaf tea extract — drove the Japanese guava leaf tea market’s development into one of the most commercially sophisticated guava leaf markets in the world. Japanese regulatory approval of guava leaf extract as a “Food for Specified Health Uses” (FOSHU) under the Japan Consumer Affairs Agency‘s functional food framework provides formal regulatory health claim validation that European and American supplement markets are progressively learning from.

Quercetin supplement — ultra-high concentration source — guava leaf’s extraordinary quercetin density (70–100mg per gram versus onion’s 1.2–2.5mg per gram) creates commercial interest for quercetin supplement manufacturers whose extraction raw material economics benefit dramatically from starting material quercetin density. Per tonne of extraction feedstock — guava leaf provides 30–50× more quercetin than onion powder — creating extraction yield economics that specifically justify guava leaf as the preferred quercetin extraction raw material for manufacturers whose products are standardised to high quercetin concentrations.

Digestive health and antidiarrheal supplement — the WHO-documented antidiarrheal clinical evidence base creates positioning for guava leaf in digestive health supplement formulations whose specific antidiarrheal communication for travellers (traveller’s diarrhoea prevention), adults with irritable bowel syndrome, and paediatric diarrhoea management creates distinct market segments. The Natural Products Association (NPA) and American Herbal Products Association (AHPA) track guava leaf within digestive health supplement development.

For supplement manufacturers requiring HPLC-documented quercetin and total polyphenol content — contact our export team to discuss extract-grade specification.

Herbal Tea Manufacturing — Japan’s FOSHU Validation Creates the Global Market Template

The global herbal tea market — tracked through Grand View Research’s herbal tea market analysis at over USD 4 billion annually — creates the largest volume commercial procurement stream for tea-grade guava leaves whose infusion-based delivery creates the most accessible consumer format for guava leaf’s functional benefits:

Japanese guava leaf tea market — the most commercially sophisticated international guava leaf market, whose FOSHU regulatory approval for blood glucose management claims has created a mainstream retail category in Japanese convenience stores, supermarkets, and health food chains. Japanese guava leaf tea market intelligence tracked through JETRO and KATI confirms guava leaf as one of Japan’s most commercially successful functional herbal teas — creating consistent high-volume procurement demand for cut-and-sifted dried guava leaves meeting Japanese food safety standards administered through the Ministry of Health, Labour and Welfare (MHLW).

Korean functional herbal tea market — whose growing adoption of Japanese-influenced functional tea culture creates developing demand for guava leaf tea tracked through KATI.

European herbal tea market — the EU herbal tea sector whose growing awareness of guava leaf’s blood glucose and antidiarrheal applications creates developing procurement demand from herbal infusion manufacturers tracked through the European Herbal & Traditional Medicine Practitioners Association (EHTPA).

African and diaspora herbal tea — the growing pan-African herbal wellness product market creates West African guava leaf tea products whose geographic origin authenticity creates cultural product positioning for diaspora wellness brands.

For herbal tea manufacturing buyers evaluating Nigerian guava leaves — contact our team to discuss cut-and-sifted specification and moisture content.

Pharmaceutical and Traditional Medicine Manufacturing

Traditional medicine pharmaceutical formulations — guava leaf is incorporated in Ayurvedic formulations (as amrood patra in Sanskrit pharmaceutical tradition), Traditional Chinese Medicine preparations for diarrhoea and dysmenorrhea management, and West African traditional medicine preparations documented through Journal of Ethnopharmacology. Pharmaceutical raw material procurement from documented, analytically tested botanical origin creates institutional supply demand from traditional medicine manufacturers whose pharmacopoeia specifications require authenticated botanical identity and documented active compound content.

WHO Essential Medicines connection — while guava leaf extract itself is not on the WHO’s Essential Medicines List, the WHO’s specific endorsement of guava leaf in primary healthcare contexts in tropical countries — documented through its traditional medicine programme — creates institutional procurement interest from NGO health programmes and government health systems whose primary healthcare delivery incorporates traditional botanical medicines in resource-limited settings.

Oral health formulation — guaijaverin’s documented antibacterial activity against Streptococcus mutans — the primary dental caries pathogen — creates commercial interest from natural oral care product manufacturers developing guava leaf-based mouthwash, toothpaste, and dental gel formulations whose natural antimicrobial positioning creates premium product differentiation in the growing natural oral care market tracked through Mintel’s global oral care innovation database.

Functional Food and Cosmetics Applications

Anti-aging and antioxidant skin care — guava leaf extract’s extraordinary total polyphenol content creates cosmetics formulation interest in antioxidant skin care, wound healing preparations, and anti-inflammatory skin treatment products. INCI nomenclature: Psidium Guajava (Guava) Leaf Extract — CIR has reviewed guava extract in cosmetics safety assessments confirming safety for topical application at appropriate concentrations.

Natural food preservative application — guava leaf extract’s documented antimicrobial activity against food spoilage organisms creates natural preservative research interest for food manufacturers whose clean-label reformulation programmes specifically replace synthetic preservatives. Research published through Journal of Agricultural and Food Chemistry confirms guava leaf extract’s food preservation efficacy against common spoilage organisms — creating functional food ingredient positioning beyond supplement and tea applications.

---

Why Buy Guava Leaves From Nigeria?

The Agricultural By-Product Economics — Leaf Value From Existing Infrastructure

Nigeria’s guava cultivation — distributed across the forest, forest-savanna, and Guinea savanna zones of the southern and Middle Belt states — creates a production geography whose leaf harvesting represents value extraction from existing agricultural infrastructure rather than new crop investment. Every guava orchard managed for fruit production generates leaf material through routine annual pruning whose commercial value — currently uncaptured by the fruit industry — is the commodity that Paradise MultiTrade’s guava leaf programme specifically monetises.

This by-product economics creates a production cost structure fundamentally different from dedicated botanical crops: the land, tree establishment, and orchard management costs are already borne by the fruit production business whose leaf material is a commercial bonus rather than a primary cost centre. The commercial consequence is competitive leaf pricing relative to producing regions whose dedicated leaf cultivation carries the full cost burden.

Quercetin Density — Superior Raw Material Economics for Extract Manufacturers

Nigerian guava leaf quercetin content — whose tropical growing conditions, adequate rainfall, and the stress-response secondary metabolite concentration pattern documented throughout this series in highland tropical crops — creates raw material whose extraction yield economics specifically favour Nigerian origin for quercetin extraction operations. At 70–100mg quercetin per gram of dried leaf — and at Nigerian production’s competitive FOB pricing — the quercetin cost per milligram from Nigerian guava leaf extraction is among the most favourable of any natural quercetin source commercially available. Contact us to discuss quercetin content documentation and extraction-grade supply.

Supply Diversification — Brazil, India, and Taiwan Currently Dominate

Brazil, India, Taiwan, and China collectively dominate internationally traded dried guava leaves — with Japanese and Korean specialty herbal tea manufacturers sourcing almost exclusively from these Asian origins. Nigerian West African origin provides geographic supply diversification whose Atlantic logistics advantage for European buyers (14–18 days Lagos to Rotterdam versus 20–25 days from Indian or Brazilian origins) and uncorrelated production climate risk creates supply chain resilience value for buyers whose current procurement is concentrated in Asian origins.

Complete Export Documentation

Every guava leaf shipment carries phytosanitary certification from NAQS, NEPC export documentation, certificate of origin, commercial invoice, packing list, and bill of lading. We coordinate botanical species identity confirmation (Psidium guajava — visual morphology and if required TLC or HPLC botanical authentication), moisture content, total polyphenol content (Folin-Ciocalteu method), quercetin content (HPLC), total flavonoid content (aluminium chloride colorimetric), aflatoxin screening, pesticide residue multi-residue analysis to EU MRL standards per Regulation (EC) 396/2005, and microbiological safety testing following AOAC International validated procedures. EU-bound shipments comply with Regulation (EU) 2017/625 on official controls and Commission Regulation (EC) 1881/2006. Our NEPC Export Licence No. 0042385 and CAC Registration No. RC-9284647 are verifiable through NEPC.

---

Nigeria’s Guava Leaf Export Strength and Global Market Demand

The Global Market

The global guava leaf market — a growing segment of the broader botanical ingredient and herbal tea markets — is tracked through Grand View Research’s herbal tea market analysis and Mordor Intelligence’s botanical extract market report with specific guava leaf growth driven by Japanese FOSHU validation, expanding blood glucose management supplement demand, and growing natural health awareness across East Asian, European, and North American markets. ITC Trade Map confirms Nigeria’s formal guava leaf trade as a developing — rather than established — export category whose formalisation through Paradise MultiTrade’s programme creates commercial infrastructure for progressive market development.

Key Export Destination Markets

Japan — the world’s most commercially developed guava leaf tea market, whose FOSHU regulatory framework and established retail infrastructure for functional herbal tea creates the most commercially sophisticated procurement community. Japanese food safety and functional food requirements administered through MHLW and Japan Consumer Affairs Agency.

South Korea — whose growing functional tea market and traditional medicine sector create developing guava leaf demand tracked through KATI.

Germany and Netherlands — Europe’s primary herbal supplement manufacturing and herbal tea distribution hubs creating consistent procurement demand for tea-grade and supplement-grade guava leaves. EU botanical supplement and food safety requirements through EFSA and EHTPA.

United Kingdom — whose growing digestive health supplement market and herbal tea culture create consistent demand. UK food safety through FSA and herbal medicine requirements through MHRA.

United States — whose blood glucose management and digestive health supplement sectors create growing guava leaf extract procurement demand tracked through FDA dietary supplement and NPA.

UAE and Gulf States — where traditional medicine use and growing wellness market create developing demand tracked through ADAFSA.

Canada — whose natural health product market creates developing guava leaf demand tracked through CFIA.

---

Why Choose Paradise MultiTrade International Limited?

Quercetin HPLC Documentation — The Premium Quality Credential. Total quercetin content quantified by HPLC — expressed as mg per gram of dried leaf and as percentage of dry weight — coordinated through accredited phytochemistry laboratories for extract manufacturing and supplement buyers whose extraction yield economics and label claim substantiation require documented quercetin concentration. Nigerian guava leaf’s 70–100mg quercetin per gram creates the raw material economics that lower-concentration alternatives cannot match. Contact us to discuss quercetin documentation.

Total Polyphenol Content — Folin-Ciocalteu Method. Total phenolic content quantified as gallic acid equivalents (GAE) per gram — providing the comprehensive antioxidant compound credential that functional food and supplement buyers use for product positioning and comparison with competing botanical sources. Contact us to discuss polyphenol documentation.

Japanese MHLW-Compatible Documentation. For buyers supplying the Japanese guava leaf tea market — we coordinate the specific analytical and safety documentation framework that Japanese food safety standards administered by MHLW require, including pesticide residue compliance to Japanese agricultural chemical registration standards. Contact our team to discuss Japanese market compliance.

Three Commercial Forms Available. Whole dried leaves (tea grade A), cut and sifted (tea grade B), and fine powder (supplement/extract grade) — from the same documented Nigerian Psidium guajava orchard sourcing network. Contact us to specify your required form.

Multi-Commodity West African Botanical Sourcing. Guava leaf buyers frequently source complementary Nigerian botanicals. Alongside guava leaves, Paradise MultiTrade exports moringa leaves, moringa leaf powder, neem leaves, neem leaf powder, bitter leaves, hibiscus flower, lemongrass, scent leaves, soursop leaves powder, cashew nut kernel, and raw cashew nuts. Explore our full range of Nigerian export commodities and consolidate your West African botanical and herbal ingredient sourcing through one verified, licensed export partner.

---

Product Specifications

---

Harvesting and Export Process

Leaf Harvesting Season. Guava is a perennial evergreen whose leaf harvesting can occur year-round — with optimal polyphenol content in leaves harvested from actively growing young branches March through October, corresponding to Nigeria’s rainy season when active vegetative growth produces the highest-phenolic young mature leaves. The harmattan season (November–February) creates slower growth and older leaves whose polyphenol content may be lower than peak growing season material. For highest-quercetin content — March–July harvest from actively growing trees is specifically scheduled.

Leaf Selection and Grading. Young mature leaves — 3rd to 6th leaf from the branch tip — harvested at the optimal expansion stage whose quercetin and polyphenol concentration is confirmed analytically at the beginning of each harvest season. Leaves selected free from insect damage, fungal spotting, and yellowing that indicates senescence-related compound degradation.

Washing and Initial Processing. Harvested leaves washed in clean potable water to remove surface soil, dust, and insect residue. Draining before drying — preventing excess surface moisture that would slow drying and create mould risk.

Drying. Washed leaves spread on raised mesh drying racks — solar dried under protective shade cloth (preventing UV-induced chlorophyll and polyphenol degradation) or mechanically dried at 45–55°C in hot-air cabinet dryers. Temperature management critical: above 60°C creates chlorophyll degradation (excessive browning) and potential quercetin oxidation whose consequences include reduced analytical content and colour quality failure. Target moisture: below 10% for whole leaf; below 8% for powder grade.

Processing to Grade. Whole dried leaves — sorted to remove damaged, discoloured, or undersized leaves — packed directly for tea grade A. Cut and sifted — dried whole leaves mechanically cut through cutter-vibrator systems to 3–8mm particle size, then sifted to remove fine dust and oversized pieces — producing tea grade B. Powder — dried whole leaves hammer-milled to 80 mesh through temperature-controlled milling.

Quality Testing. Moisture, total polyphenol (Folin-Ciocalteu), quercetin HPLC, aflatoxin (ELISA), pesticide residue (multi-residue analysis), microbiological — tested before export documentation. Heavy metals ICP-MS for supplement and pharmaceutical grade buyers.

Lead Times. Whole dried leaves from growing season stock: 14–21 days. Cut and sifted: 21–28 days. Powder: 21–35 days. Full analytical panel (HPLC quercetin, heavy metals): add 7–10 days. Contact us to plan your supply schedule.

---

Frequently Asked Questions

What is the clinical evidence for guava leaf tea’s blood glucose management effect and how strong is it?

The clinical evidence for guava leaf’s post-prandial blood glucose management is among the most specifically documented in functional herbal tea science — whose strength specifically motivated Japan’s regulatory approval of guava leaf extract as a FOSHU (Food for Specified Health Uses) product with permitted blood glucose management health claims. Key research accessible through NCBI: Japanese randomised controlled trials in pre-diabetic subjects consuming guava leaf tea (one tea bag, 150ml water, consumed with meals) documented statistically significant reduction in post-meal blood glucose AUC (area under the curve) of 20–30% versus placebo tea, with no significant effect on fasting blood glucose. The mechanism — alpha-glucosidase inhibitory activity of apigenin, quercetin, and luteolin in guava leaf extract reducing the rate of intestinal starch digestion to glucose — is the same mechanism as the pharmaceutical alpha-glucosidase inhibitor drug acarbose, but at lower potency and without acarbose’s gastrointestinal side effects. For supplement brands developing blood glucose management products incorporating guava leaf — the Japanese FOSHU approval provides regulatory precedent and the published clinical trials provide specific human evidence reference. The evidence specifically supports post-meal blood glucose peak reduction rather than fasting blood glucose reduction — an important distinction for regulatory claim communication. Contact us to discuss extract-grade guava leaves for blood glucose management formulation.

Why does guava leaf have higher quercetin content than almost any other botanical and how does this affect extract manufacturing economics?

Guava leaf’s extraordinary quercetin concentration — 70–100mg per gram of dried leaf — reflects the specific secondary metabolite investment that Psidium guajava‘s evolutionary history has created in its leaf tissue. Quercetin’s role in guava leaf tissue is protective — ultraviolet radiation screening (protecting leaf photosynthetic apparatus), herbivory deterrence (quercetin’s bitter flavour reduces palatability to generalist insect herbivores), and antimicrobial activity (preventing fungal leaf infections) — with the tropical forest environment of guava’s native range and adopted habitats creating consistent selection pressure for high quercetin leaf content as a defence investment. For extract manufacturers — the specific economic implication: producing a quercetin supplement capsule standardised to 250mg quercetin requires 2.5g of guava leaf dry weight as the extraction starting material. The same capsule produced from onion powder (1.2–2.5mg quercetin per gram) would require 100–200g of onion powder as extraction starting material — a 40–80× raw material weight differential whose cost and processing economics make guava leaf the overwhelmingly preferred quercetin extraction raw material for high-standardisation products. Research confirming guava leaf quercetin concentration published through Journal of Agricultural and Food Chemistry essential oil and polyphenol characterisation studies. Contact us to discuss extract-grade quercetin concentration specification.

What is the traditional antidiarrheal use of guava leaves and what clinical evidence supports it?

Guava leaf’s antidiarrheal use — documented across traditional medicine systems in Nigeria, Brazil, India, Mexico, and Southeast Asia through research accessible via Journal of Ethnopharmacology — represents one of the most geographically widespread convergent traditional medical prescriptions for any single botanical. The cross-cultural validation whose significance we have emphasised throughout this series — independent parallel discovery by unconnected medical traditions — here encompasses five continents and dozens of distinct traditional medicine systems prescribing guava leaf specifically for diarrhoea management. The pharmacological mechanism is multi-component: (1) Intestinal motility reduction — quercetin and ellagic acid’s smooth muscle calcium channel modulation reduces intestinal hypermotility — the excessive peristalsis that drives the rapid transit and fluid secretion characteristic of diarrhoeal illness. (2) Antimicrobial activity — guava leaf extract’s documented minimum inhibitory concentrations against E. coli, Salmonella typhi, Shigella dysenteriae, and Staphylococcus aureus — the primary bacterial enteropathogens causing infectious diarrhoea — create direct antibacterial activity complementing the motility reduction. (3) Astringent mucus membrane effect — condensed tannins’ protein-precipitating activity on intestinal mucosal proteins reduces intestinal secretion and creates a protective surface layer. Clinical human trials — including a study in Nigerian children with acute diarrhoea published in Journal of Pediatric Gastroenterology and accessible through NCBI — documented significantly shorter illness duration (2.0 days vs 3.3 days in untreated controls) in guava leaf treatment groups. Contact us to discuss antidiarrheal supplement-grade specification.

What is Japan’s FOSHU designation for guava leaf and why does it matter internationally?

Japan’s FOSHU (Food for Specified Health Uses — Tokuho in Japanese) is a regulatory framework administered by the Japan Consumer Affairs Agency (CAA) that permits specific health claims on food products whose efficacy has been demonstrated through human clinical trials reviewed by the CAA. Guava leaf extract is approved as a FOSHU ingredient specifically for the health use claim: “helps suppress the rise of blood glucose level after a meal” — making guava leaf one of a relatively small number of botanical extracts to achieve formal Japanese government health claim approval. The commercial significance internationally: (1) Regulatory precedent — Japan’s clinical trial evidence review process whose rigour is broadly comparable to European EFSA health claim evaluation provides independent regulatory validation that EU and US supplement manufacturers can reference. (2) Market development template — Japan’s commercially successful guava leaf tea market demonstrates consumer acceptance and commercial viability that European and North American markets can develop toward. (3) Specification alignment — Japanese FOSHU-approved guava leaf products use specific extract standardisation parameters whose adoption as quality benchmarks by international buyers provides a practical specification framework. (4) Documentation template — the specific clinical evidence package that achieved FOSHU approval provides the evidence template whose structure guides supplement manufacturers in other markets building their own regulatory dossiers. For supplement manufacturers developing guava leaf products for Japanese market distribution — our Japanese MHLW-compatible documentation package coordinates the specific analytical and safety documentation that Japanese import and FOSHU compliance requires. Contact us to discuss Japanese market-specific documentation.

What is the EU Novel Food status of guava leaves and how should European buyers navigate this?

Guava leaves’ EU Novel Food regulatory status — under Regulation (EU) 2015/2283 — is commercially nuanced and requires specific attention from European food manufacturing buyers: (1) Historical consumption context: Guava fruit has long-established food use in the EU through importation for fresh consumption and processed food use. However, guava leaf as a specifically consumed food ingredient (rather than fruit) may not have the same documented significant consumption history in EU member states prior to May 1997 — the Novel Food Regulation’s baseline date. (2) Southern European use context: Portugal, Spain, and Italy — whose historical tropical colonial connections and subsequent immigrant communities — may provide documented guava leaf consumption history pre-1997 that supports a traditional food status claim rather than Novel Food authorisation. (3) Current market reality: Guava leaf herbal tea is sold in EU botanical supplement retail and health food stores without systematic Novel Food enforcement — reflecting regulatory pragmatism for botanicals with limited commercial footprint. (4) Recommended approach: EU food manufacturers building guava leaf-containing products at commercial food manufacturing scale should obtain specific legal advice from an EU food regulatory specialist before market launch — consulting national food safety authorities in target markets (Germany: BVL; Netherlands: NVWA; UK: FSA) to confirm whether their specific product format requires Novel Food authorisation. Dietary supplement use (as botanical supplement extract capsules) follows different regulatory pathways that may have lower Novel Food barriers than food use. Contact us to discuss EU regulatory navigation.

How should guava leaf tea be prepared to maximise blood glucose management benefit?

The Japanese clinical studies that achieved FOSHU regulatory approval used a specific preparation protocol whose parameters — documented through NCBI’s clinical trial database — provide the evidence-based preparation guidance for tea manufacturers and consumers seeking clinical benefit: (1) Standard preparation: 1 tea bag or approximately 3g of dried guava leaves steeped in 150–200ml of 90–95°C water for 3–5 minutes — producing a pale yellow-green infusion. (2) Timing: Consumed with or immediately before meals — the alpha-glucosidase inhibitory mechanism requires guava leaf polyphenols to be present in the intestinal lumen simultaneously with dietary starch for maximum blood glucose peak reduction. Post-meal consumption after digestion has already begun provides reduced benefit. (3) Concentration: Studies using higher concentration (2 tea bags per cup, 5+ minutes steeping) produced stronger blood glucose effects — consistent with dose-dependent pharmacology. (4) Regularity: Daily use at each main meal created the most consistent blood glucose management benefit in clinical studies — reflecting the mechanism’s requirement for regular intestinal polyphenol presence rather than a pharmacokinetic drug accumulation effect. For herbal tea manufacturers — the clinical protocol creates an evidence-based brewing recommendation that can be communicated on packaging alongside the blood glucose management benefit, providing consumers with specific use guidance that differentiates evidence-based functional tea from generic wellness positioning. Contact us to discuss tea-grade cut-and-sifted specification optimised for clinical preparation.

What transit times should I expect from Nigeria?

Dried guava leaves (whole, cut and sifted, and powder) — standard dry container, no temperature control required: UK (Tilbury, Felixstowe) — 14–18 days from Lagos. Netherlands (Rotterdam) — 14–18 days. Germany (Hamburg) — 14–20 days. France (Le Havre) — 14–18 days. Italy (Genoa, Naples) — 12–16 days. USA (East Coast — New York, Baltimore, Savannah) — 18–25 days. Canada (Halifax, Montreal) — 18–28 days. UAE (Jebel Ali) — 10–14 days. Japan (Yokohama) — 25–32 days. South Korea (Busan) — 30–38 days. India (Nhava Sheva, Mundra) — 10–15 days. Air freight (UK Heathrow) — 2–3 days total. Air freight (Japan Narita/Tokyo) — 3–4 days total (recommended for Japanese market buyers whose premium fresh-season material procurement justifies air freight premium). Transit comparison vs Brazilian or Indian origin for European buyers: Lagos to Rotterdam 14–18 days versus São Paulo/India to Rotterdam approximately 20–25 days — approximately 6–10 day Atlantic logistics advantage. Packaging note: Dried guava leaves — particularly cut and sifted and powder — are hygroscopic and subject to UV-induced polyphenol oxidation. Sealed inner polyethylene liner within outer kraft bag is mandatory; opaque packaging prevents light-induced degradation of green chlorophyll colour and flavonoid compounds during transit. Add 7–10 days for HPLC quercetin analysis and heavy metals ICP-MS before loading for supplement-grade lots. Contact us to plan your complete logistics programme.

---

Ready to Source Nigerian Dried Guava Leaves — Whole Leaves, Cut and Sifted Tea Grade, and Supplement Powder — With HPLC Quercetin Documentation, Total Polyphenol Certification, Botanical Species Authentication, Japanese MHLW-Compatible Documentation, EU Pesticide Residue Compliance, and Full Analytical Documentation for Nutraceutical Supplement Brands, Herbal Tea Manufacturers, Blood Glucose Management Product Developers, and Global Wholesale Buyers?

If you are a Japanese or Korean herbal tea manufacturer building guava leaf tea supply from a West African origin whose Atlantic-equivalent quality and competitive FOB pricing provides supply diversification from Taiwanese, Brazilian, or Indian dominant origins whose MHLW food safety compliance and FOSHU-aligned analytical documentation your procurement requires, a European or American nutraceutical supplement brand developing blood glucose management, quercetin antioxidant, or digestive health products incorporating guava leaf extract whose HPLC-documented quercetin density (70–100mg per gram) creates extraction yield economics that lower-concentration botanical alternatives cannot match, a pharmaceutical raw material buyer sourcing Psidium guajava leaf for traditional medicine formulation or botanical pharmaceutical development whose botanical authentication documentation, total polyphenol characterisation, and pharmacopoeia-level analytical quality standards require a formally documented tropical botanical supply programme, a natural oral care product manufacturer developing guava leaf-based mouthwash, toothpaste, or dental gel formulations whose guaijaverin antibacterial activity against dental caries pathogens creates the scientific foundation for natural antimicrobial oral care positioning, a cosmetics formulator developing antioxidant skin care, wound healing, or anti-aging formulations incorporating Psidium guajava leaf extract whose extraordinary total polyphenol content creates premium antioxidant positioning, or a global botanical ingredient trader building Nigerian guava leaf supply positions for Japanese, Korean, European, and North American herbal tea and supplement markets as West African botanical origin gains commercial recognition — Paradise MultiTrade International Limited is the licensed Nigerian exporter your guava leaf supply programme needs.

We supply Nigerian Psidium guajava dried guava leaves — whole tea grade A, cut and sifted tea grade B, and supplement/extract grade powder — from Ogun, Ondo, Anambra, and Plateau state orchard sourcing, botanical species authenticated per lot, HPLC quercetin content certified, total polyphenol Folin-Ciocalteu documented, Japanese MHLW pesticide residue compliance available on request, aflatoxin and mycotoxin ELISA tested, EU pesticide residue MRL compliant, heavy metals ICP-MS for supplement and pharmaceutical grade, and exported with full botanical and food safety documentation to buyers in every major regulated destination market.

Request a Quotation — share your required form (whole leaves, cut and sifted, or powder), quercetin content minimum, total polyphenol specification, Japanese MHLW documentation requirement, EU Novel Food regulatory guidance need, volume, application (herbal tea, blood glucose supplement, quercetin extraction, digestive health, oral care, cosmetics, pharmaceutical), destination market, and preferred incoterms. We respond within 48 hours.

Contact Our Export Team — speak directly about HPLC quercetin analysis and extraction raw material economics, Japanese FOSHU-aligned documentation for blood glucose management tea products, total polyphenol Folin-Ciocalteu documentation, botanical authentication (guaijaverin marker confirmation), EU Novel Food regulatory navigation, antidiarrheal clinical evidence documentation for digestive health supplement formulation, organic certification potential from traditional low-input orchard management, and long-term supply programme structuring.

Explore Our Full Product Range — alongside guava leaves, Paradise MultiTrade exports moringa leaves, moringa leaf powder, neem leaves, neem leaf powder, bitter leaves, hibiscus flower, lemongrass, scent leaves, onion powder, cashew nut kernel, shea butter, and raw cashew nuts. One licensed Nigerian exporter. One consolidated West African botanical leaf, herbal tea, spice, oilseed, and natural food sourcing relationship — from the agricultural by-product whose quercetin density is 40–80× higher than the quercetin source that gets all the scientific press to the most clinically validated traditional antidiarrheal botanical in West African medicine.

---

Paradise MultiTrade International Limited | NEPC Export Licence No. 0042385 | CAC No. RC-9284647 | Lagos, Nigeria | www.paradisemultitrade.com